Concepedia

Regina Loomis

RL

Statistics

Publications

14

Citations

711

H-Index

12

Active since

1980

Affiliations

Yale University(Current)

Yale Cancer Center

Temple University

Bristol-Myers Squibb (United States)

Regina Loomis is an author at Yale University specializing in cancer pharmacology, oncology, and life sciences.

Publications per year

1980–2024

14

Publications

14

Triapine (3-aminopyridine-2-carboxaldehyde- thiosemicarbazone): A potent inhibitor of ribonucleotide reductase activity with broad spectrum antitumor activity

Rick A. Finch, Mao‐Chin Liu, Susan P. Grill et al. · Biochemical Pharmacology · 2000 · 367 citations

, , +8

Antitumor 2-(Aminocarbonyl)-1,2-bis(methylsulfonyl)-1-(2-chloroethyl)- hydrazines

Krishnamurthy Shyam, Philip G. Penketh, Regina Loomis et al. · Journal of Medicinal Chemistry · 1996 · 53 citations

, , +8

Synthesis and evaluation of 1,2,2-tris(sulfonyl)hydrazines as antineoplastic and trypanocidal agents

Philip G. Penketh, A A Divo, Regina Loomis et al. · Journal of Medicinal Chemistry · 1990 · 43 citations

, , +6

Bcl-2 antisense (G3139, Genasense) enhances the in vitro and in vivo response of Epstein-Barr virus-associated lymphoproliferative disease to rituximab.

Regina Loomis, Rocco Carbone, Jill Lacy · PubMed · 2003 · 37 citations

, , +17

Effects of Sodium Pentobarbital on the Radiation Response of EMT6 Cells in Vitro and EMT6 Tumors in Vivo

Sara Rockwell, Regina Loomis · Radiation Research · 1980 · 33 citations

, , +17

1–5 of 14